Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guangdong VTR Bio-Tech Co Ltd
Common Shares Outstanding
Guangdong VTR Bio-Tech Co Ltd
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
|
Common Shares Outstanding
¥491.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
|
Beigene Ltd
HKEX:6160
|
Common Shares Outstanding
¥1.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Common Shares Outstanding
¥1.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Common Shares Outstanding
¥563.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Common Shares Outstanding
¥921.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Common Shares Outstanding
¥219.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Guangdong VTR Bio-Tech Co Ltd
Glance View
Guangdong VTR Bio-Tech Co., Ltd. is engaged in the research & development, production, sales and service of biological pharmacy, bio-enzyme preparation, microbe preparation, functional additives and green bio-manufacturing engineering. The company is headquartered in Zhuhai, Guangdong and currently employs 2,807 full-time employees. The company went IPO on 2014-01-28. The firm principally engages in the manufacture and distribution of feedstuff additives, additive pre-mixed feedstuffs, veterinary powders and granules. The Company’s products include enzyme preparations for feedstuffs, including composite enzyme for feedstuffs, phytase for feedstuffs and xylanase for feedstuffs, among others; bio-energy enzyme preparations; spinning enzyme products; food enzyme products; paper making enzyme products; other feedstuff additives, including antioxidants, acidifiers, attractants and fructo oligo saccharides feedstuff additives, as well as veterinary Chinese medicines.
See Also
What is Guangdong VTR Bio-Tech Co Ltd's Common Shares Outstanding?
Common Shares Outstanding
491.1m
CNY
Based on the financial report for Sep 30, 2025, Guangdong VTR Bio-Tech Co Ltd's Common Shares Outstanding amounts to 491.1m CNY.
What is Guangdong VTR Bio-Tech Co Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
5%
Over the last year, the Common Shares Outstanding growth was 2%.
